新聞

首頁 > 新聞中心 > 新聞

2026/02/24

司美替尼硫酸鹽(Selumetinib Sulfate)晶型獲得美國專利

The United States Patent and Trademark Office has granted Chunghwa Chemical Synthesis & Biotech Co. Ltd (CAS/CCSB) a patent of “Crystal Forms A、B、C、D、E、F and G of Selumetinib Sulfate and Preparation Methods Thereof. ” (Patent no. US 12,552,751 B2) on 17th February, 2026.